Genetic study of proteins is a breakthrough in drug development for complex diseases

An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol, has demonstrated how genetic data can be used to support drug target prioritisation by identifying the causal effects of proteins on diseases.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Health, International, Postgraduate, Public engagement, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Biological Sciences, Faculty of Science, Faculty of Science, School of Biological Sciences, Faculty of Health Sciences, Faculty Source Type: news